Recent 8-K filings for COSM

• May 22, 2026, 9:30 AM ET earnings materiality 0.65 neutral item 2.02item 9.01

  Cosmos Health Q1 revenue +31% to $17.93M; net loss widens to $2.81M

  Q1 revenue $17.93M, up 31% YoY from $13.71M; adjusted revenue $18.40M (+34.2%).

• April 16, 2026, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01 ◈ Earnings Releases

  Cosmos Health reports record FY2025 revenue $65.3M, up 20%; gross profit +83%, adjusted EPS improves 82%

  Revenue $65.3M (+20% YoY); gross profit $7.9M (+83%); gross margin 12.1% (+418 bps).

• December 18, 2025, 6:59 PM ET regulatory materiality 0.60 negative item 3.01item 9.01 ◈ Listing & Compliance Notices

  Cosmos Health receives Nasdaq bid-price deficiency notice; 180-day cure period

  Received non-compliance letter on Dec 11, 2025 for bid price below $1.00 for 30 consecutive business days.

• November 17, 2025, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Cosmos Health Q3 2025 revenue $17.1M (+38% YoY), record gross margin 15.2%, cash jumps to $4.63M

  Q3 2025 revenue $17.11M (up 38% YoY); gross profit $2.60M (+116%), gross margin 15.21% (vs 9.72%).

• October 17, 2025, 7:59 PM ET regulatory materiality 0.70 positive item 7.01item 8.01item 9.01

  Cosmos Health regains compliance with Nasdaq minimum bid price requirement

  Received Nasdaq notice on Oct 15, 2025 confirming compliance with Minimum Bid Price Rule.

• October 6, 2025, 7:59 PM ET leadership materiality 0.20 neutral item 5.02item 9.01

  Cosmos Health appoints Theodoros Karkantzos to Board of Directors

  Appointed effective September 30, 2025, term expiring at 2026 annual meeting.

• October 1, 2025, 7:59 PM ET other material materiality 0.65 neutral item 5.02item 5.07item 5.03item 9.01 ◈ Governance Changes

  Cosmos Health shareholders approve 1.5B common share increase and reverse split authorization at 2025 annual meeting

  Elected six directors: Siokas, Demetriades, Hoidas, Aslidis, Bhutawala, Karkantzos with majority votes.

• September 29, 2025, 7:59 PM ET other material materiality 0.75 positive item 7.01item 9.01

  Cosmos Health CEO letter details $300M digital asset facility, H1 revenue up 11.7%, 2027 guidance

  Secured $300M senior secured convertible note; 72.5% net proceeds to digital treasury (ETH, BTC, SOL).

• August 11, 2025, 7:59 PM ET debt materiality 0.65 neutral item 1.01item 2.03item 3.02item 9.01

  Cosmos Health closes $8M senior secured convertible note with 9% OID, conversion at $1.05

  Issued $8M original principal 9% senior secured convertible note to institutional investor on August 7, 2025.

• August 6, 2025, 7:59 PM ET other material materiality 0.85 positive item 1.01item 2.03item 3.02item 8.01item 9.01 ◈ Debt Financings

  Cosmos Health secures up to $300M convertible note facility for Ethereum treasury strategy

  Up to $300M in 9% senior secured convertible notes; initial $8M close on Aug 6, 2025.

• May 7, 2025, 7:59 PM ET regulatory materiality 0.50 neutral item 3.01item 9.01

  Cosmos Health receives Nasdaq extension to Nov 3, 2025 for minimum bid price compliance

  Nasdaq granted 180-day extension through Nov 3, 2025 to meet $1.00 minimum bid price rule.

• February 18, 2025, 6:59 PM ET other material materiality 0.30 neutral item 7.01item 9.01

  Cosmos Health postpones S-1 offering until after 2024 10-K filing

  Cosmos Health will not proceed with its Form S-1 offering until after filing the 2024 Annual Report on Form 10-K.

• January 29, 2025, 6:59 PM ET debt materiality 0.50 neutral item 2.03item 9.01

  Cosmos Health subsidiary CosmoFarm issues €2.2M secured bond at Euribor+2.95%, matures 2030

  CosmoFarm S.A. issued €2.2M ($2.29M) secured bond from a European bank on Jan 27, 2025.

• January 22, 2025, 6:59 PM ET other material materiality 0.60 neutral item 1.01item 9.01

  Cosmos Health enters exclusive license for two cancer-treatment patents; up to EUR 7.5M buy-out

  Exclusive worldwide license for two patents (filed 2016, 2017) to treat cancer; commercialize via R&D and trials.

• November 21, 2024, 6:59 PM ET other materiality 0.30 neutral item 5.07

  Cosmos Health shareholders approve reverse split authorization, elect directors at annual meeting

  All six director nominees elected; Grigorios Siokas received 90.6% approval, John Hoidas lowest at 69.4%.

• November 12, 2024, 6:59 PM ET regulatory materiality 0.75 negative item 3.01item 9.01

  Cosmos Health receives Nasdaq bid price deficiency notice; 180-day cure period

  Nasdaq notified Cosmos Health of non-compliance with minimum $1.00 bid price rule as of Nov 6, 2024.

• September 27, 2024, 7:59 PM ET other material materiality 0.85 positive item 1.01item 3.02item 9.01

  Cosmos Health enters warrant exchange agreement, issues 9.7M new warrants at $0.95

  Holder exercised 4,874,126 December 2023 warrants at reduced price of $0.8701 per share.

• July 22, 2024, 7:59 PM ET regulatory materiality 0.50 positive item 8.01item 9.01

  Cosmos Health regains Nasdaq minimum bid price compliance

  Received Nasdaq notification on July 19, 2024 that it regained compliance with Listing Rule 5550(a)(2).

• May 28, 2024, 7:59 PM ET regulatory materiality 0.75 negative item 4.01item 3.01item 9.01

  Cosmos Health receives additional Nasdaq delinquency notice for late 10-K and 10-Q filings

  Received Nasdaq delinquency letter on May 21, 2024 for failure to timely file Q1 2024 Form 10-Q and remaining delinquent on 2023 Form 10-K.

• May 3, 2024, 7:59 PM ET other material materiality 0.78 negative item 4.01item 9.01 ◈ Auditor Changes

  Cosmos Health dismisses KPMG amid dispute over inventory transactions; appoints RBSM

  KPMG dismissed on April 26, 2024 after failing to complete 2023 audit timely; cites unresolved inventory concerns.

• May 2, 2024, 7:59 PM ET other material materiality 0.80 negative item 4.01item 9.01 ◈ Auditor Changes

  Cosmos Health dismisses KPMG, hires RBSM; KPMG flags possible illegal act, company disagrees

  Dismissed KPMG as auditor immediately on April 26, 2024; KPMG unable to complete 2023 audit on time.

• April 26, 2024, 7:59 PM ET other material materiality 0.75 negative item 4.01item 9.01 ◈ Auditor Changes

  Cosmos Health dismisses KPMG as auditor; KPMG unable to complete FY2023 audit on time

  Dismissed KPMG effective April 26, 2024; Audit Committee unanimous vote.

• April 25, 2024, 7:59 PM ET other material materiality 0.55 neutral item 1.01item 3.03item 9.01 ◈ Material Agreements

  Cosmos Health adopts shareholder rights plan (poison pill) with 20% trigger

  Board declared dividend of one right per common share outstanding as of April 19, 2024.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.65 · Most common event other_material

7 positive 6 negative 10 neutral

source · COSM on sec.gov